drugset / Trial / NCT07671755
Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pneumonia Treatment
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to evaluate clinical outcomes of colistin versus colistin in combination with cefoperazone-sulbactam for patients with MDR-AB VAP treatment.
Timeline
- Start
- 2025-02-01
- Primary completion
- 2025-12-30
- Completion
- 2026-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Colistin | Other / unclassified | — | — |
| Subject | cefoperazone-sulbactam | Unknown | — | — |
Indications
No indication recorded.